- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00489879
Management of Patients With Type 2 Diabetes and Hypertension Using Mobile Health Care System
Efficacy of Mobile Health Care System in Patients With Type 2 Diabets and Hypertension
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Diabetes care is facilitated by a patient's being engaged in a self-management program with the advice and counsel of physicians, but many diabetic patients can not receive the continous monitoing and advice from his physician in their every day life. It is very difficult to keep up life style modification in their real life.
Few studies have examined the effects of cellular phone based intervention that provide an interactive component daily. Our goal is to test the hypothesis that diabetes and hypertension management using cellular phone based health care system would result in significant improvement of blood glucose and blood pressure level.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
VD
-
Seoul, VD, Korea, Republic of, 152-703
- Department of Internal Medicine, Korea University College of Medicine
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- type II diabetes using only oral hypoglycemic agents
- 7% < HbA1c < 10%
- systolic blood pressure > 130 or diastolic blood pressure > 80
- BMI > 23
- 20 < age < 75
Exclusion Criteria:
- type I diabetes or type II diabtes using insulin treatment
- liver, renal or heart disease
- recent change (within 1 month) in the type or dosage of anti-diabetic agent, anti-hypertensive medication
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
HbA1c, fasting blood glucose level, Weight change, Blood pressure level in the morning, lipid profiles
Time Frame: baseline, 3months later
|
baseline, 3months later
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
exercise time during one week, self reported change in dietary habit, fat consumption ratio
Time Frame: baseline, 3months later
|
baseline, 3months later
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Kyung M Choi, MD, Department of Internal Medicine, Korea University College of Medicine
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Seoul R&BD Program
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertension
-
National Taiwan University Hospital Hsin-Chu BranchRecruitingHypertension,Essential | Hypertension, MaskedTaiwan
-
University of Alabama at BirminghamTroy UniversityCompletedHypertension | Hypertension, Resistant to Conventional Therapy | Uncontrolled Hypertension | Hypertension, White CoatUnited States
-
BayerCompletedPrimary HypertensionChina
-
Addpharma Inc.Recruiting
-
Columbia UniversityAgency for Healthcare Research and Quality (AHRQ)Active, not recruitingWhite Coat Hypertension | Hypertension,EssentialUnited States
-
Universidade Federal de Santa MariaCompletedHealthy Volunteers | Hypertension, EssentialBrazil
-
Sulaiman AlRajhi CollegesUnknownHypertension, Essential | β-hydroxybutyrate
-
Centre Chirurgical Marie LannelongueUnknownChronic Thrombo-embolic Pulmonary Hypertension and Pulmonary Arterial HypertensionFrance
-
Sheffield Teaching Hospitals NHS Foundation TrustUniversity of SheffieldCompletedIdiopathic Pulmonary Arterial Hypertension | Chronic Thromboembolic Pulmonary HypertensionUnited Kingdom
Clinical Trials on Mobile Health Care System (DrUB)
-
Monash UniversityCaring Pharmacy; Bionime Corporation; Tigas PharmaActive, not recruiting
-
Ji Youl LeeUnknown
-
Gadjah Mada UniversityUniversitas Islam IndonesiaRecruitingPreDiabetes | Prediabetic StateIndonesia
-
Akdeniz UniversityCompletedAdolescent | Asthma in Children | Self Efficacy | Nursing CareTurkey
-
George Washington UniversityCompleted
-
Clemson UniversityU.S. Army Medical Research and Development Command; Madigan Army Medical CenterCompletedDiabetes Mellitus, Type 2United States
-
Far Eastern Memorial HospitalCompleted
-
Chang Gung Memorial HospitalUnknown
-
Indiana UniversityNational Cancer Institute (NCI)Not yet recruitingPediatric Cancer
-
Edward Via Virginia College of Osteopathic MedicineAuburn UniversityCompletedOverweight and Obesity | Health BehaviorUnited States